From yahoo! finance…

MISTR, the largest telemedicine provider offering free online PrEP and long-term HIV care in all 50 states, D.C., and Puerto Rico, is now prescribing Doxycycline Post-Exposure Prophylaxis (DoxyPEP), an antibiotic that reduces bacterial STIs, including gonorrhea, chlamydia, and syphilis. Beginning today, patients can now use MISTR’s seamless telehealth platform to receive DoxyPEP online for free.

With this launch, MISTR plans to further solve the issue of access and adherence to PrEP and HIV care, and now offers patients access to post-exposure care, in addition to their existing preventive and long-term HIV treatment options, which include PrEP and antiretroviral therapy (ART). This comes at a time when the rate of STIs continue to rise – in 2022, more than 2.5 million cases of syphilis, gonorrhea, and chlamydia were reported in the U.S.; of that population, gay and bisexual men are disproportionately affected.

“Despite an ongoing STI epidemic affecting the LGBTQ+ community, there are few resources available for this underserved, vulnerable community to get the preventative medication they need,” said Tristan Schukraft, CEO and Founder of MISTR. “I’m proud that MISTR is democratizing access to PrEP, HIV Care, and now DoxyPEP.”

Read the full article.